Paper36332
Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin).
van Hees PA and 3 others. Gut, 1979. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin). Papers, record 36332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36332
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin).
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Intestinal Mucosa | Major topic |
| Sulfasalazine | Major topic |
| Aminosalicylic Acids | |
| Colitis | |
| Diarrhea | |
| Feces | |
| Humans | |
| Male | |
| Sulfapyridine | |
| Time Factors |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13865153 | Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. | Lancet | 1962 | https://conductscience.org/library/papers/13865153 | PubMed |
| 2 | 14218553 | CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS. | Gut | 1964 | https://conductscience.org/library/papers/14218553 | PubMed |
| 3 | 14238045 | PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION. | Lancet | 1965 | https://conductscience.org/library/papers/14238045 | PubMed |
| 4 | 4145285 | Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine. | Acta Pharm Suec | 1973 | https://conductscience.org/library/papers/4145285 | PubMed |
| 5 | 4146996 | Determination of salicylazosulphapyridine in biological materials. | Acta Pharm Suec | 1973 | https://conductscience.org/library/papers/4146996 | PubMed |
| 6 | 4147555 | The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients. | Gut | 1973 | https://conductscience.org/library/papers/4147555 | PubMed |
| 7 | 4150435 | A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). | Gut | 1973 | https://conductscience.org/library/papers/4150435 | PubMed |
| 8 | 4402886 | Absorption, metabolism, and excretion of salicylazosulfapyridine in man. | Clin Pharmacol Ther | 1972 | https://conductscience.org/library/papers/4402886 | PubMed |
| 9 | 4405598 | Distribution studies of salicylazosulfapyridine and its metabolites. | Gastroenterology | 1973 | https://conductscience.org/library/papers/4405598 | PubMed |
| 10 | 72239 | An experiment to determine the active therapeutic moiety of sulphasalazine. | Lancet | 1977 | https://conductscience.org/library/papers/72239 | PubMed |
| 11 | 747 | Colorimetric determination of 5-aminosalicylic acid and its N-acetylated metabolite on urine and feces. | Res Commun Chem Pathol Pharmacol | 1975 | https://conductscience.org/library/papers/747 | PubMed |
| 12 | 74700 | Active therapeutic moiety of sulphasalazine. | Lancet | 1978 | https://conductscience.org/library/papers/74700 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18484800 | Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes. | Drugs | 2008 | https://conductscience.org/library/papers/18484800 | PubMed |
| 12113642 | Comparative tolerability of therapies for ulcerative colitis. | Drug Saf | 2002 | https://conductscience.org/library/papers/12113642 | PubMed |
| 8620678 | The influence of multiple oral doses of zileuton on the steady-state pharmacokinetics of sulfasalazine and its metabolites, sulfapyridine and N-acetylsulfapyridine. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/8620678 | PubMed |
| 6345112 | Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. | Dig Dis Sci | 1983 | https://conductscience.org/library/papers/6345112 | PubMed |
| 6119205 | Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6119205 | PubMed |
| 6114897 | Sulphasalazine and male infertility: reversibility and possible mechanism. | Gut | 1981 | https://conductscience.org/library/papers/6114897 | PubMed |
| 6114023 | Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study. | Gut | 1981 | https://conductscience.org/library/papers/6114023 | PubMed |
| 6107263 | Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. | Gut | 1980 | https://conductscience.org/library/papers/6107263 | PubMed |
| 3780113 | Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazone. | Clin Pharmacokinet | 1986 | https://conductscience.org/library/papers/3780113 | PubMed |
| 3567055 | Release of 5-aminosalicylic acid from Pentasa during normal and accelerated intestinal transit time. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3567055 | PubMed |
| 3356364 | Secretory effect of azodisalicylate (azodisal sodium) on the short circuited mucosa of the rat ileum in vitro. | Gut | 1988 | https://conductscience.org/library/papers/3356364 | PubMed |
| 3207553 | Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3207553 | PubMed |
| 2878859 | Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy. | Gut | 1986 | https://conductscience.org/library/papers/2878859 | PubMed |
| 2877884 | 5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/2877884 | PubMed |
| 2864155 | Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. | Clin Pharmacokinet | 1985 | https://conductscience.org/library/papers/2864155 | PubMed |
| 2840367 | Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis. | Gut | 1988 | https://conductscience.org/library/papers/2840367 | PubMed |
| 2686883 | Clinical pharmacokinetic considerations in the elderly. An update. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2686883 | PubMed |
| 2199130 | Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II). | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2199130 | PubMed |
| 1975737 | Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease. | Ann Rheum Dis | 1990 | https://conductscience.org/library/papers/1975737 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36332
GET https://conductscience.org/api/papers/v1/36332/authors